This information was published on 2025-07-21T10:22:28 for IP Right Registration Published.
| Field | Value |
| (210) | 2544225 (IR 1852714) |
| (220) |
06 Mar 2025
|
| (300) |
US, 12 Sep 2024, 98746837
|
| (511) (510) |
Class 5
Pharmaceutical preparations for use in connection with the prevention and treatment of cancer, inflammatory conditions, immunological disorders, neoplastic conditions, rare genetic diseases, cardiovascular conditions, infectious diseases, and neurological conditions; pharmaceutical preparations; biomedical compounds for medical purposes, namely, peptides and miniproteins and cell-penetrating peptides and cell-penetrating miniproteins (CPMPs) arrays for diagnosing cancer, inflammatory conditions, immunological disorders, cardiovascular conditions, infectious diseases, and neurological conditions. Class 42 Drug discovery services; scientific research and development; providing information in the field of scientific research and development in the biotechnology and pharmaceutical fields; scientific research and development in the field of biotechnology and pharmaceuticals. |
| (540) | PARABILIS MEDICINES |
| (550) | Word |
| (730) |
PARABILIS MEDICINES, INC.
|
Find out more about publications on the About page.